Merck, BMS Target Aurobindo Over Generic HIV Drug
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. sued Aurobindo Pharma Ltd. in New Jersey federal court on Wednesday, alleging the Indian drugmaker is trying to introduce its own version...To view the full article, register now.
Already a subscriber? Click here to view full article